e.g. Tata motors, Reliance MF, 500570

Beta Drugs Ltd. - Research Center

Group () BSE data
 
Back to Company Page
Results:
Statement:

Profit loss account

(Rs crore)
Mar ' 24 Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20
Income
Operating income 197.62 157.87 124.85 79.46 65.32
Expenses
Material consumed 114.44 85.62 72.50 44.38 35.33
Manufacturing expenses 15.01 13.04 10.35 8.48 7.29
Personnel expenses 14.32 13.42 8.72 6.06 4.93
Selling expenses 0.02 0.03 0.06 - 0.05
Adminstrative expenses 20.31 14.57 8.03 5.23 5.97
Expenses capitalised - - - - -
Cost of sales 164.10 126.68 99.66 64.15 53.57
Operating profit 33.53 31.20 25.18 15.31 11.75
Other recurring income 1.73 1.04 0.86 0.61 0.42
Adjusted PBDIT 35.26 32.24 26.04 15.92 12.17
Financial expenses 1.05 0.84 0.41 0.77 0.64
Depreciation 4.72 6.19 5.47 5.27 2.58
Other write offs - - - - -
Adjusted PBT 29.48 25.21 20.16 9.88 8.95
Tax charges 7.55 6.39 5.92 2.90 1.85
Adjusted PAT 21.94 18.82 14.25 6.98 7.10
Non recurring items - - - - -
Other non cash adjustments - - - - -
Reported net profit 21.94 18.82 14.25 6.98 7.10
Earnigs before appropriation 84.64 62.72 44.11 29.86 22.89
Equity dividend - - - - -
Preference dividend - - - - -
Dividend tax - - - - -
Retained earnings 84.64 62.72 44.11 29.86 22.89
Close
Add Beta Drugs Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Beta Drugs Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback